API Production for Viral Vaccines and Viral Vectors

Product description

API production for pre-clinical, clinical and commercial supply- Validation of aseptic processes
- Cell and virus banking 
- Using own seed cell banks: VERO and DF-1, Duck cell line (AGE-1)
- API production using different TechnologiesMVA Know-How

IDT Biologika is considered the global leader in MVA (Modified Vaccinia Ankara) and recombinant and non-recombinant poxvirus technologies and aseptic processing

Contact us for more information
Read more

Specifications

Categories BiopharmaceuticalsCell & Gene therapy; APIsSera and Vaccines; Contract Services - Contract Services
Sales markets Western Europe; Eastern Europe; Asia; North America
Supplied from Germany; United States

More products from IDT Biologika GmbH

Products from other suppliers